304 related articles for article (PubMed ID: 30007542)
1. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
[TBL] [Abstract][Full Text] [Related]
2. Comparisons of efficacy and complications between transrectal and transperineal prostate biopsy with or without antibiotic prophylaxis.
He J; Guo Z; Huang Y; Wang Z; Huang L; Li B; Bai Z; Wang S; Xiang S; Gu C; Pan J
Urol Oncol; 2022 May; 40(5):191.e9-191.e14. PubMed ID: 35168882
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
[TBL] [Abstract][Full Text] [Related]
5. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: A propensity score-matched study.
Jiang CY; Shen PF; Wang C; Gui HJ; Ruan Y; Zeng H; Xia SJ; Wei Q; Zhao FJ
Asian J Androl; 2019; 21(6):612-617. PubMed ID: 31006712
[TBL] [Abstract][Full Text] [Related]
7. Comparison between Ultrasound Guided Transperineal and Transrectal Prostate Biopsy: A Prospective, Randomized, and Controlled Trial.
Guo LH; Wu R; Xu HX; Xu JM; Wu J; Wang S; Bo XW; Liu BJ
Sci Rep; 2015 Nov; 5():16089. PubMed ID: 26526558
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
[No Abstract] [Full Text] [Related]
9. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
[TBL] [Abstract][Full Text] [Related]
14. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
[TBL] [Abstract][Full Text] [Related]
15. Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem.
Seitz M; Stief C; Waidelich R; Bader M; Tilki D
World J Urol; 2017 Nov; 35(11):1681-1688. PubMed ID: 28470334
[TBL] [Abstract][Full Text] [Related]
16. Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Diamand R; Guenzel K; Mjaess G; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Bui AP; Taha F; Oderda M; Gontero P; Rysankova K; Bernal-Gomez A; Mastrorosa A; Roche JB; Fiard G; Abou Zahr R; Ploussard G; Windisch O; Novello Q; Benamran D; Delavar G; Anract J; Barry Delongchamps N; Halinski A; Dariane C; Benijts J; Assenmacher G; Roumeguère T; Peltier A
Eur Urol Focus; 2024 Mar; ():. PubMed ID: 38508895
[TBL] [Abstract][Full Text] [Related]
17. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis.
Noreikaite J; Jones P; Fitzpatrick J; Amitharaj R; Pietropaolo A; Vasdev N; Chadwick D; Somani BK; Rai BP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):153-160. PubMed ID: 29487398
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
Ongün S; Aslan G; Avkan-Oguz V
Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
D'Elia C; Mian C; Hanspeter E; Ladurner C; Palermo SM; Pycha S; Saleh O; Cai T; Spoladore G; Kafka M; Pycha A; Trenti E
Urol Int; 2019; 103(4):433-438. PubMed ID: 31614361
[TBL] [Abstract][Full Text] [Related]
20. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
